- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05966831
Metacognitive Self Control and Job Interview Training
October 29, 2025 updated by: Matthew Smith, University of Michigan
A Randomized Effectiveness Trial of Metacognitive Self Control and Job Interview Training
The study is a randomized controlled trial (RCT) that assesses the effectiveness of a metacognitive self-control training intervention (MCT) in conjunction with virtual-reality job interview training (VR-JIT) in a sample of formerly incarcerated individuals.
The study also includes an implementation evaluation.
Study Overview
Status
Terminated
Conditions
Detailed Description
The goal is to conduct a randomized controlled trial (RCT) that assesses the effectiveness of a metacognitive self-control training intervention (MCT) in conjunction with virtual-reality job interview training (VR-JIT) in a sample of formerly incarcerated individuals, as well as complete an implementation evaluation.
Participants will be recruited who who: 1) have previously been incarcerated (e.g., jail, prison), 2) have reentered society, 3) 18 years of age or older, 4) currently are a part of the A Brighter Way program.
A Brighter Way is a local re-entry program in Ypsilanti, Michigan (MI) that focuses on helping formerly incarcerated individuals (living in Washtenaw county) build stable and successful lives.
Participants will be randomly assigned to conditions where they either receive both MCT and VR-JIT interventions, or where they receive an Active-Control Activity and VR-JIT intervention (with an allocation ratio of 1:1).
To assess the effectiveness of MCT, researchers plan to compare behavioral and self-report measures of self-control pre and post interventions, as well as assess employment and recidivism outcomes.
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years or older
- Actively enrolled in A Brighter Way Program
- 3rd grade reading level or higher
Exclusion Criteria:
- Has uncorrected hearing or visual problem that prevents them from using the training
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Metacognitive Self-Control Training (MCT) + Virtual Reality Job Interview Training (VR-JIT)
This group will receive the MCT intervention plus the VR-JIT intervention.
We are anticipating 6-8 weeks, with 1-3 sessions per week for each intervention.
|
Metacognitive Self-Control Training (MCT) was originally developed by the Michigan Skills Project for students in middle/high school.
The MCT training intervention has been updated to be suitable for adults.
MCT is a lecture style intervention that encompasses 13 modules (over the course of 4 weeks) on improving self-control that is to be delivered in a community setting.
Across the training, participants will learn new "tools" for improving self-control.
VR-JIT provides trainees with an opportunity to repeatedly practice interviewing for a job at fictional company 'Wondersmart'.
Prior to interviewing, trainees review self-guided e-learning materials on how to find, prepare for, succeed in, and follow-up on job interviews that includes the review of 10 job interview skills.
Trainees also complete an online job application for one of 14 jobs (e.g., cashier, clerical, customer service, food services, inventory, janitorial, web developer) that informs the virtual interview experience.
|
|
Experimental: Virtual Reality Job Interview Training (VR-JIT)
This group will receive just the VR-JIT intervention.
We are anticipating 6-8 weeks, with 1-3 sessions per week for this intervention.
|
VR-JIT provides trainees with an opportunity to repeatedly practice interviewing for a job at fictional company 'Wondersmart'.
Prior to interviewing, trainees review self-guided e-learning materials on how to find, prepare for, succeed in, and follow-up on job interviews that includes the review of 10 job interview skills.
Trainees also complete an online job application for one of 14 jobs (e.g., cashier, clerical, customer service, food services, inventory, janitorial, web developer) that informs the virtual interview experience.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Self-Control Measured by Brief Self-Control Scale (BSCS)
Time Frame: Baseline and posttest (approximately 8 weeks after baseline)
|
The measure is a Likert Scale style questionnaire.
13 items are scored from 1 (not at all) to 5 (Very much).
The total score is calculated from adding all items together and higher scores indicate higher levels of self-control.
|
Baseline and posttest (approximately 8 weeks after baseline)
|
|
Change in Self-Control Measured by Barratt Impulsiveness Scale
Time Frame: Baseline and posttest (approximately 8 weeks after baseline)
|
The measure is a Likert Scale style questionnaire.
30 items are scored from 1 (Rarely/Never) to 4 (Almost Always/Always).
The total score is calculated from adding all items together and range from 30 to 120; higher scores indicate higher levels of impulsiveness.
|
Baseline and posttest (approximately 8 weeks after baseline)
|
|
Change in Self-Control Measured by Short Form Self-Regulation Questionnaire
Time Frame: Baseline and posttest (approximately 8 weeks after baseline)
|
The measure is a Likert Scale style questionnaire.
31 items are scored from 1 (Strongly Disagree) to 5 (Strongly Agree).
The total score is calculated from adding all items together.
Higher scores indicate higher self-regulation capacity.
|
Baseline and posttest (approximately 8 weeks after baseline)
|
|
Change in Employment Outcome
Time Frame: Baseline and 9 Month Follow Up (9 Months after randomization)
|
Employment survey indicating that participants are either employed (1) or unemployed (0).
|
Baseline and 9 Month Follow Up (9 Months after randomization)
|
|
Change in Adult Attention Deficit/Hyperactivity Disorder (ADHD) Symptomology measured by ADHD Self-Report Scale (ASRS)
Time Frame: Baseline and posttest (approximately 8 weeks after baseline)
|
The Adult ADHD Self-Report Scale (ASRS) is an instrument consisting of the eighteen Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV TR) criteria.
Six of the eighteen questions were found to be the most predictive of symptoms consistent with ADHD.
These six questions are the basis for the ASRS v1.1 Screener and are also Part A of the Symptom Checklist.
Part B of the Symptom Checklist contains the remaining twelve questions.
All questions utilize a Likert scale from Never, Rarely, Sometimes, Often, to Very Often.
|
Baseline and posttest (approximately 8 weeks after baseline)
|
|
Change in Adult Attention Deficit/Hyperactivity Disorder (ADHD) Symptomology measured by the Structured Clinical Interview (SCID-RV) for The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
Time Frame: Baseline and posttest (approximately 8 weeks after baseline)
|
The Structured Clinical Interview (SCID-RV) for DSM-5 for Adult Attention-Deficit/Hyperactivity Disorder measures ADHD symptomology.
The module is made up of 5 major criteria with items in each criteria using a 3 point Likert scale ranging from 1 "absent or False" to 3 "threshold or true".
This module uses a dichotomous scoring method that indexes whether a symptom is present or not.
Only responses of "threshold or true" are coded as symptom present, while responses of "subthreshold" or "absent or false" are coded as symptom absent, so each individual will have a score of symptom absent = 0, and symptom present = 1 for criteria A through E.
|
Baseline and posttest (approximately 8 weeks after baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Recidivism
Time Frame: Baseline and throughout 9 Month Follow Up (9 Months after randomization)
|
Researchers will track if a participant becomes re-incarcerated throughout the entire study.
This will be marked as Yes (1) or No (0) in our database tracking.
|
Baseline and throughout 9 Month Follow Up (9 Months after randomization)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2023
Primary Completion (Actual)
December 9, 2024
Study Completion (Actual)
December 9, 2024
Study Registration Dates
First Submitted
July 14, 2023
First Submitted That Met QC Criteria
July 25, 2023
First Posted (Actual)
August 1, 2023
Study Record Updates
Last Update Posted (Estimated)
October 31, 2025
Last Update Submitted That Met QC Criteria
October 29, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00234352
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Recidivism
-
VA Office of Research and DevelopmentRecruitingCriminal Behavior | Psychosocial Functioning | Criminal RecidivismUnited States
-
Pacific UniversityCompleted
-
Medstar Health Research InstituteCompletedViolence | RecidivismUnited States
-
The University of Hong KongThe Hong Kong Jockey Club Charities TrustRecruiting
-
Ginger YangUniversity of Iowa; Ohio State University; University of NebraskaCompletedCommunication | Recidivism | Drive | Feedback, PsychologicalUnited States
-
Ginger YangUniversity of Iowa; Ohio State University; University of NebraskaRecruitingCommunication | Recidivism | Drive | Feedback, PsychologicalUnited States
-
University of California, San FranciscoCompletedClinically Severe Obesity | Weight Regain | Obesity Recidivism | Weight RecidivismUnited States
-
University of Texas at AustinNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedDrinking Behavior | Injury RecidivismUnited States
-
Meaningful Measurement, IncNational Institute on Drug Abuse (NIDA); University of Massachusetts, WorcesterActive, not recruitingMental Health Disorder | Criminal Recidivism | Substance Use Disorder (SUD)United States
Clinical Trials on Metacognitive Self-Control Training (MCT)
-
ZI-YU LINCompletedSchizophrenia | Bipolar Disorder | Major Depressive DisorderTaiwan
-
University Hospital, Strasbourg, FranceNot yet recruitingSchizophrenia Spectrum Disorder
-
Instituto de Investigación Sanitaria de la Fundación...Universidad Autonoma de MadridUnknownSchizophrenia Spectrum and Other Psychotic DisordersSpain
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Universitat Autonoma de BarcelonaHospital Son Espases; Parc Sanitari Sant Joan de Déu; Andaluz Health Service; Hospital... and other collaboratorsRecruitingSchizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Delusional Disorder | Schizophreniform Disorders | Brief Psychotic DisorderSpain
-
University of British ColumbiaVancouver Coastal Health Research Institute; Vancouver General Hospital; Vancouver... and other collaboratorsTerminatedSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | PsychosisCanada
-
Fundació Sant Joan de DéuParc Sanitari Sant Joan de Déu; Solidaritat Sant Joan de Déu; FluidraRecruiting
-
University of JyvaskylaVanha Vaasa HospitalRecruitingPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | Psychotic Depression | Delusional DisorderFinland
-
University of Sao PauloActive, not recruiting
-
University of GaziantepNot yet recruitingObsessive-Compulsive Disorder